🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SNG
$SNGX
🔒 US EquitiesSoligenix Inc
AVG HISTORICAL GAP
+0.60%
MAX GAP RECORD
+6.67%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SNGX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SNGX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN) |
-2.56%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+6.45%
|
| Nov 07, 2025 Earnings Release 2025-11-07 (AFTER CLOSE) |
+3.65%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE) |
-4.08%
|
| May 09, 2025 Earnings Release 2025-05-09 (AFTER CLOSE) |
+1.01%
|
| Mar 21, 2025 Earnings Release 2025-03-21 (AFTER CLOSE) |
-2.93%
|
| Nov 08, 2024 Earnings Release 2024-11-08 (AFTER CLOSE) |
+0.86%
|
| Aug 09, 2024 Earnings Release 2024-08-09 (AFTER CLOSE) |
-1.91%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.1%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (1)
📖 Intelligence Summary
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗